Quantum-Si (NASDAQ:QSI) CEO Sells $15,308.68 in Stock

Posted by Brian Himes on Sep 23rd, 2026

Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) CEO Jeffrey Hawkins sold 20,143 shares of the company’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $0.76, for a total transaction of $15,308.68. Following the sale, the chief executive officer directly owned 3,649,659 shares in the company, valued at approximately $2,773,740.84. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jeffrey Alan Hawkins also recently made the following trade(s):

On Tuesday, September 22nd, Jeffrey Hawkins sold 9,709 shares of Quantum-Si stock. The shares were sold at an average price of $0.76, for a total transaction of $7,378.84.

Quantum-Si Stock Performance

Shares of Quantum-Si stock traded down $0.03 during trading hours on Wednesday, reaching $0.76. 1,450,049 shares of the company were exchanged, compared to its average volume of 1,472,687. The firm has a market cap of $166.06 million, a PE ratio of -1.65 and a beta of 3.25. Quantum-Si Incorporated has a 1 year low of $0.69 and a 1 year high of $3.10. The stock’s fifty day moving average is $0.77 and its 200 day moving average is $0.88.

Quantum-Si (NASDAQ:QSI – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative return on equity of 47.12% and a negative net margin of 6,138.26%.The firm had revenue of $0.34 million during the quarter, compared to analyst estimates of $0.30 million. Research analysts expect that Quantum-Si Incorporated will post -0.47 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have commented on QSI shares. Weiss Ratings cut shares of Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 9th. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research note on Friday, August 14th. Finally, Wall Street Zen upgraded Quantum-Si from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $1.00.

Read Our Latest Research Report on QSI

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in QSI. IPG Investment Advisors LLC acquired a new stake in Quantum-Si in the second quarter valued at about $27,000. WINTON GROUP Ltd purchased a new stake in shares of Quantum-Si in the second quarter valued at approximately $67,000. Corient Private Wealth LP acquired a new position in Quantum-Si during the second quarter worth $34,000. Green Alpha Advisors LLC purchased a new position in Quantum-Si in the second quarter worth $41,000. Finally, Renaissance Technologies LLC acquired a new stake in Quantum-Si in the first quarter valued at $91,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

About Quantum-Si

(Get Free Report)

Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.

Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.